These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15792359

  • 1. The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.
    Korotaeva AA, Samoilova EV, Kaminny AI, Pirkova AA, Resink TJ, Erne P, Prokazova NV, Tkachuk VA, Chazov EI.
    Mol Cell Biochem; 2005 Feb; 270(1-2):107-13. PubMed ID: 15792359
    [Abstract] [Full Text] [Related]

  • 2. [Serum level of secretory phospholipase A2 (sPLA2) as a predictor of restenosis after coronary angioplasty].
    Korotaeva AA, Provatorov SI, Samoĭlova EV, Kaminnyĭ AI, Sumarokov AB, Pirkova AA, Samko AN, Prokazova NV.
    Ter Arkh; 2002 Feb; 74(4):12-5. PubMed ID: 12043230
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M, Bandlow N, Tietge UJ, Grote K, Pfeilschifter J, Kaszkin M, Beck S, Drexler H, Schieffer B.
    Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
    [Abstract] [Full Text] [Related]

  • 4. Secretory phospholipases A2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor.
    Ikeno Y, Konno N, Cheon SH, Bolchi A, Ottonello S, Kitamoto K, Arioka M.
    J Biol Chem; 2005 Jul 29; 280(30):28044-52. PubMed ID: 15927955
    [Abstract] [Full Text] [Related]

  • 5. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K, Yamada K, Yamamoto S, Ishimoto Y, Saiga A, Ono T, Ikeda M, Notoya M, Kamitani S, Arita H.
    J Biol Chem; 2002 Aug 09; 277(32):29116-24. PubMed ID: 12021277
    [Abstract] [Full Text] [Related]

  • 6. New phospholipase A(2) isozymes with a potential role in atherosclerosis.
    Murakami M, Kudo I.
    Curr Opin Lipidol; 2003 Oct 09; 14(5):431-6. PubMed ID: 14501581
    [Abstract] [Full Text] [Related]

  • 7. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
    Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, Berliner JA.
    Arterioscler Thromb Vasc Biol; 1999 May 09; 19(5):1291-8. PubMed ID: 10323782
    [Abstract] [Full Text] [Related]

  • 8. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition.
    Ghesquiere SA, Gijbels MJ, Anthonsen M, van Gorp PJ, van der Made I, Johansen B, Hofker MH, de Winther MP.
    J Lipid Res; 2005 Feb 09; 46(2):201-10. PubMed ID: 15576846
    [Abstract] [Full Text] [Related]

  • 9. Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells.
    Sonoki K, Iwase M, Sasaki N, Ohdo S, Higuchi S, Takata Y, Iida M.
    Br J Pharmacol; 2008 Apr 09; 153(7):1399-408. PubMed ID: 18264128
    [Abstract] [Full Text] [Related]

  • 10. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
    Wooton-Kee CR, Boyanovsky BB, Nasser MS, de Villiers WJ, Webb NR.
    Arterioscler Thromb Vasc Biol; 2004 Apr 09; 24(4):762-7. PubMed ID: 14962950
    [Abstract] [Full Text] [Related]

  • 11. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?
    Kanemitsu S, Takekoshi N, Matsui S, Tsugawa H, Ohkubo S, Kitayama M, Matsuda T, Senma J, Masuyama K, Yamagata T, Murakami E.
    Ther Apher; 1998 Feb 09; 2(1):65-70. PubMed ID: 10227791
    [Abstract] [Full Text] [Related]

  • 12. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.
    Pruzanski W, Lambeau L, Lazdunsky M, Cho W, Kopilov J, Kuksis A.
    Biochim Biophys Acta; 2005 Sep 05; 1736(1):38-50. PubMed ID: 16122976
    [Abstract] [Full Text] [Related]

  • 13. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
    Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Hashida K.
    Am Heart J; 1996 Jul 05; 132(1 Pt 1):23-9. PubMed ID: 8701872
    [Abstract] [Full Text] [Related]

  • 14. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.
    Ivandic B, Castellani LW, Wang XP, Qiao JH, Mehrabian M, Navab M, Fogelman AM, Grass DS, Swanson ME, de Beer MC, de Beer F, Lusis AJ.
    Arterioscler Thromb Vasc Biol; 1999 May 05; 19(5):1284-90. PubMed ID: 10323781
    [Abstract] [Full Text] [Related]

  • 15. Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X.
    Pruzanski W, Kopilov J, Kuksis A.
    Prostaglandins Other Lipid Mediat; 2016 Jan 05; 122():64-8. PubMed ID: 26711221
    [Abstract] [Full Text] [Related]

  • 16. Telmisartan and N-acetylcysteine suppress group V secretory phospholipase A2 expression in TNFα-stimulated human endothelial cells and reduce associated atherogenicity.
    Sonoki K, Iwase M, Ohdo S, Ieiri I, Matsuyama N, Takata Y, Kitazono T.
    J Cardiovasc Pharmacol; 2012 Oct 05; 60(4):367-74. PubMed ID: 22743636
    [Abstract] [Full Text] [Related]

  • 17. Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study.
    Wootton PT, Arora NL, Drenos F, Thompson SR, Cooper JA, Stephens JW, Hurel SJ, Hurt-Camejo E, Wiklund O, Humphries SE, Talmud PJ.
    Hum Mol Genet; 2007 Jun 15; 16(12):1437-44. PubMed ID: 17545304
    [Abstract] [Full Text] [Related]

  • 18. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
    Horie H, Takahashi M, Izumi M, Takaoka A, Fujita T, Sakamoto T, Kito O, Okamura H, Kinoshita M.
    Circulation; 1997 Jul 01; 96(1):166-73. PubMed ID: 9236431
    [Abstract] [Full Text] [Related]

  • 19. Potential involvement of type II phospholipase A2 in atherosclerosis.
    Hurt-Camejo E, Camejo G.
    Atherosclerosis; 1997 Jul 11; 132(1):1-8. PubMed ID: 9247353
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease].
    Pirkova AA, Samoĭlova EV, Ameliushkina VA, Kaminnyĭ AI, Titov VN, Prokazova NV, Naumov VG, Kucharchuk VV, Korotaeva AA.
    Kardiologiia; 2007 Jul 11; 47(4):37-40. PubMed ID: 18260836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.